BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Clinical Study Validates Sequenta’s LymphoSIGHT™ Platform as More Sensitive Alternative to Flow Cytometry for Cancer Detection


10/16/2012 10:21:47 AM

SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. today announced the publication in the journal BLOOD of two landmark studies involving more than 150 patients that demonstrate the company’s LymphoSIGHT™ next generation sequencing method is more sensitive than existing tools for detecting minimal residual disease (MRD). These studies provide clinical validation for the use of the LymphoSIGHT™ platform in the treatment of B cell acute lymphoblastic leukemia (ALL); the most common childhood cancer.

Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->